Upload
nguyenphuc
View
215
Download
0
Embed Size (px)
Citation preview
School of Life and Medical Sciences Title of Programme: MSc Pharmacovigilance and Pharmacoepidemiology Programme Code: HHMPVPE
Programme Specification This programme specification is relevant to students entering: 01 September 2015 Associate Dean of School (Academic Quality Assurance): Philomena Shaughnessy Signature
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
2
Programme Specification MSc Pharmacovigilance and
Pharmacoepidemiology This programme specification (PS) is designed for prospective students, enrolled students, academic staff and potential employers. It provides a concise summary of the main features of the programme and the intended learning outcomes that a typical student might reasonably be expected to achieve and demonstrate if he/she takes full advantage of the learning opportunities that are provided. More detailed information on the teaching, learning and assessment methods, learning outcomes and content for each module can be found in Definitive Module Documents (DMDs) and Module Guides.
Section 1 Awarding Institution/Body University of Hertfordshire Teaching Institution University Bordeaux, Segalen, France
Autonomous University of Barcelona represented by Catalan Institute of Pharmacology, Spain
Erasmus Medical Centre, Rotterdam, Netherlands
Utrecht University, Netherlands
University of Verona, Italy
University of Hertfordshire University/partner campuses University Bordeaux, Segalen, France
Autonomous University of Barcelona represented by Catalan Institute of Pharmacology, Spain
Erasmus Medical Centre, Rotterdam, Netherlands
Utrecht University, Netherlands
University of Verona, Italy
College Lane, University of Hertfordshire
Programme accredited by Not applicable Final Award MSc All Final Award titles Pharmacovigilance and Pharmacoepidemiology FHEQ level of award Language of Delivery type all languages that have been approved
7 English
A. Programme Rationale Pharmacovigilance is the detection, assessment and prevention of the adverse effects of medicines and pharmacoepidemiology is the study of medicine use and effects in the population. The University of Hertfordshire is a member of a consortium comprising the five other European universities indicated above, the European and French Medicines Agencies and 15 pharmaceutical companies which secured EU funding to develop a Pan-European Masters degree in Pharmacovigilance and Pharmacoepidemiology (termed ‘Eu2P’). The rationale of the programme is to deliver an e-learning masters course, jointly validated, taught and awarded by the principal European pharmacovigilance educational institutes and supported by the European Federation of Pharmaceutical Industries and Associations. The programme is designed to recruit both new graduates in health or life sciences and professionals working in the field of pharmacovigilance/pharmacoepidemiology. A key feature is that one half of the programme will consist of conducting a project in placement with a pharmaceutical company to enable the student to undertake a research project within the industry. Graduates of the programme will be equipped for employment in the pharmaceutical and health-related industries, related regulatory authorities and academic research.
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
3
B. Educational Aims of the Programme The programme has been devised in accordance with the University's graduate attributes of programmes of study as set out in UPR TL03. Additionally this programme aims to: 1. engender a continuing and independent approach to learning, encouraging initiative and self-
discipline such that students will be able to comprehend, contribute to, and apply advances, in pharmacovigilance and pharmacoepidemiology;
2. build and improve on students’ cognitive skills, including the ability to think logically and independently; to be reflective and critical of scientific hypotheses; to analyse, synthesise and be creative;
3. provide not only specialist knowledge but also a perspective of broad intellectual, ethical and social contexts;
4. provide a flexible framework for the acquisition of a comprehensive understanding of pharmacovigilance and pharmacoepidemiology skills applicable to their own current and future research, advanced scholarship and professional practice;
5. develop an ability to apply the knowledge ( 3 above) and skills (4 above) to inform judgments and develop and advance ideas in the discipline.
C. Intended Learning Outcomes
The programme provides opportunities for students to develop and demonstrate knowledge and understanding, skills and other attributes in the following areas. The programme outcomes are referenced to the Frameworks for Higher Education Qualifications of UK Degree-Awarding Bodies (2014), and relate to the typical student. Additionally, the SEEC Credit Level Descriptors for Further and Higher Education 2010 have been used as a guiding framework for curriculum design.
Knowledge and Understanding of:
Teaching/learning methods & strategies
Assessment
A1-the main epidemiological and statistical principles, concepts and tools that are used in pharmacoepidemiology and pharmacovigilance practices and research
A2- the worldwide regulations and guidelines concerning pharmacovigilance
A3-the clinical, pharmacological and epidemiological principles underlying the prescribing of medicines and their effectiveness evaluation.
A4-the principles of PV from the development of the science to its place in pre and post-authorisation environment and the roles of various stake holders within PV
A5- the evaluation of the effects of medicines from epidemiological and public health points of view
Acquisition of knowledge and understanding is through a combination of e-studies, live interactive tutoring, e-exercises, e-quizzes and case studies. Throughout, the learner is encouraged to undertake independent study both to supplement and consolidate what is being taught/learnt and to broaden their individual knowledge and understanding of the subject. Throughout, the learner is encouraged to undertake independent study both to supplement and consolidate what is being taught/learnt and to broaden their individual knowledge and understanding of the subject.
Knowledge and understanding are assessed through a combination of unseen examinations, case studies, on-line workshops, written reports and oral presentations.
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
4
A6- the basic principles of medicines risk communication, its tools and its place in mitigating risks linked to the use of medicines
Intellectual skills - able to: Teaching/learning methods & strategies
Assessment
B1-Analyse and critically evaluate experimental, pharmaco-epidemiological data and adverse drug reactions
B2-analyse benefit-risk assessment methods (including pharmacoeconomics), the process of decision making and communication on medicines by different stakeholders
B3-To identify and quantify risks of medicine, interpret publications and results
B4- be able to draw upon elements of the regulatory environment to explain pharmacovigilance principles.
Intellectual skills are developed through case studies, e-learning tutorials and presentations and e-discussion groups. Throughout, the learner is encouraged to develop intellectual skills further by independent study. Throughout, the learner is encouraged to develop intellectual skills further by independent study
Intellectual skills are assessed through problem-solving exercises, case studies and written assignments.
Practical skills - able to: Teaching/learning methods & strategies
Assessment
C1-apply the main health indices used to describe mortality and morbidity of the population
C2-apply the methodology used in epidemiological studies and randomized clinical trials to assess the efficacy and effectiveness of medicine
C3-qualitatively and quantitatively analyse the utilization of medicines
C4-design studies and write protocols to quantify and analyse safety signals or risks
C5-to apply benefit-risk assessment methods in daily practice
Practical skills are developed through e-tutorials, e-based materials, on-line group discussions, data analysis and case studies.
Practical skills are assessed through the preparation of written protocols, design of PV and PE procedures and the analysis of data.
Transferable skills - able to: Teaching/learning methods & strategies
Assessment
D1-communicate written and oral scientific results.
D2-Present and support an
Transferable skills are developed through e-discussions, by undertaking the project within an
Transferable skills are assessed through written and oral reports, particularly
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
5
D. Programme Structures, Features, Levels, Modules, and Credits The programme is offered in full-time (2 years) and part-time (4 years) modes, and leads to the award of MSc Pharmacovigilance and Pharmacoepidemiology. Entry is normally at first year Masters (7) with qualifications described in Section F. Entry may also be granted directly into the second year as indicated in Section 7. Intake is normally semester A (September). The Eu2P Programme Board may award Eu2P Certificates* to individuals taking single, or multiple modules, in recognition of successful completion of these modules. Entry to such modules will require the same qualifications as those specified for entry to the Masters programme. Programme Structure The programme structure and progression information below (Table 1a and 1b) is provided for the award. Any interim awards are identified in Table 1b. The Programme Learning Outcomes detailed above are developed and assessed through the constituent modules. Table 2 (in section 2) identifies where each learning outcome is assessed. The key features of the structure are: • Each year of the programme is composed of 60 ECTS credits. • All modules in the first year of the programme are mandatory. • There are six compulsory taught modules in the second year of the programme. A student chooses
additional modules to facilitate specialization in any one of five “Tracks”, indicated in Figure 1, giving a total of 10 modules (30 ECTS credits). Tracks 2 and 3 specify a further 3 modules (9 ECTS) whilst tracks 1, 4 and 5 specify a further 2 modules each (6 ECTS). The remaining credits comprise modules within other tracks; thus students taking Tracks 4 and 5 study one module outside the specialism Track whereas students taking Tracks 2, 6 or 7 study two modules outside the specialism Track.
• A student may take a broader programme designated “a la carte” in which the six compulsory modules (18 ECTS) are supplemented by four modules (12 ECTS) chosen from the remaining modules.
• All students undertake a Research Project in each year carrying 30 ECTS credits each. The projects are undertaken on a placement within a pharmaceutical company or research organization.
* Eu2P certificate is used to denote modules studied at 3 or 6 ECTs points - no postgrad award from UPR AS11 is awarded
extended argument D3-demonstrate the ability to
carry out a defined task, solve it in a set period of time and adequately report the results of this work in a written report and in an oral presentation
D4-demonstrate skills in searching medical and scientific literature
D5-manage information
internship with support from the project tutor and experience gained in an industrial situation Throughout, the learner is encouraged to develop transferable skills by maintaining a record of evidence and completing a personal development plan. Throughout, the learner is encouraged to develop transferable skills by maintaining a record of evidence and completing a personal development plan.
the project report.
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
6
Table 1a Outline Programme Structure
Mode of study Full Time Entry point Semester A
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
7
Compulsory Modules Module Title
Modu
le C
od
e
Cre
dit P
oin
ts
Lang
uag
e o
f
Deliv
ery
% E
xam
ination
% C
ours
ew
ork
% P
ractica
l
Sem
este
rs
Basics in epidemiology applied to PV and PE
D1M1 3 English 0 100 0 A
Basics in statistics applied to PV and PE
D1M2 3 English 0 100 0 A
Tools to do research applied to PV and PE
D1M3 6 English 0 100 0 A
Basics in clinical pharmacology D2M1 3 English 0 100 0 A
Principles of pharmacovigilance D3M1 7LFS1020
3 English 0 100 0 A
Basics in pharmacoepidemiology D6M1 3 English 0 100 0 A
Basics in communication applied to D7M1 3 English 0 100 0 A
PV and PE Tutored project D1M4 6 English 0 100 0 B Research Project 1 30 English 0 100 0 B
Year 2
Clinical and pharmacological principles of PV and PE
D2M2 3 English 0 100 0 A
Pharmacovigilance Regulations D3M2 7LFS1021
3 English 0 100 0 A
Principles of recognizing adverse events and safety signals
D4M1 3 English 0 100 0 A
Introduction to benefit risk assessment and pharmacoeconomics in decision making
D5M1 3 English 0 100 0 A
Drug utilization studies: introduction and quantitative methods
D6M2 3 English 0 100 0 A
Needs and objectives in communication risk and benefit-risk related to medicines
D7M2 3 English 0 100 0 B
Research Project 2 30 English 0 100 0 A
Optional Modules Module Title
Modu
le C
od
e
Cre
dit P
oin
ts
Lang
uag
e o
f
Deliv
ery
% E
xam
ination
% C
ours
ew
ork
% P
ractica
l
Sem
este
rs
Methods in clinical research, PE and the assessment of efficacy of medicines
D2M3 3 English 0 100 0 A
Critical appraisal of clinical trials: Evidence-based medicine and its uncertainties
D2M4 3 English 0 100 0 A
PV regulatory processes D3M3 LFS1022
3 English 0 100 0 A
Substantiation of risks 1 D4M2a 3 English 0 100 0 A
Substantiation of risks 2 D4M2b 3 English 0 100 0 A
Identifying susceptibility to adverse drug reactions
D4M3 3 English 0 100 0 A
Principles of pharmacoeconomics and valuation of health states
D5M2 3 English 0 100 0 A
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
8
Methods for quantitative benefit-risk assessment of medicines
D5M3 3 English 0 100 0 A
Application of quantitative benefit-risk assessment in decision making on medicines
D5M4 3 English 0 100 0 A
Drug utilization studies: qualitative methods
D6M3 3 English 0 100 0 A
The public health impact of adverse drug reactions
D6M4 3 English 0 100 0 A
Challenges in medicines: risk communication
D7M3 3 English 0 100 0 A
Case studies D7M4 3 English 0 100 0 A
The award of a MSc in Pharmacovigilance and Pharmacoepidemiology requires 240 credits (120 ECTS credits). Table 1b Final and interim awards available The programme provides the following final and interim awards:
Award Minimum requirements Available at end of (normally):
Masters Pharmacovigilance and Pharmacoepidemiology
180 credit points including at least 150 at level 7 3 Semesters
Masters awards can be made "with Distinction" or "with Commendation" where criteria, as described in the Eu2P Masters Regulations and the Eu2P Master Regulations for trainees, are met.
E. Support for students and their learning Students are supported by;
An academic advisor (belonging to a University partner) to support the student in the choice and execution of the project(s).
A Research Project Director belonging to the host organization at which the project is carried out. A full description of the support given is described in the ‘Eu2P Masters Regulation’.
A residential induction programme termed “Freshers’ week”.
Access to the Eu2P e-learning platform
Support in the use of the Eu2P e-learning platform from lecturers, facilitators, administrative staff and a technical support team
Academic support from lecturers and facilitators
Representation on the Eu2P Education Board
Studynet access – a versatile on-line intranet learning environment giving access to UH electronic journals and books and full access to learning resources of other Eu2P universities.
Eu2P central office in the University of Bordeaux
Supporting documentation summarising the Eu2P regulations entitled “Eu2P Master Trainee Regulations: The Master Trainee’s code of rights and obligations.
A careers service at the University of Hertfordshire
An equal opportunities officer F. Entry requirements The minimum admission criteria for entry to the first year of the Eu2P Master are:
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
9
For all applicants: Bachelors’ degree (180 ECTS credits / 3 years) or equivalent in Health or Life sciences
A personal letter of motivation to participate in the Eu2P Master.
Applicants whose native language is not English, the candidates should provide one of the following English certificates with min. score: IELTS: 6.5 (with no score below 6) Paper‐based TOEFL: 580 Computer‐based TOEFL: 237 Internet‐based TOEFL: 92 Certificate of Advanced English: B/C Certificate of Proficiency in English: B/C
For applicants working in an English environment, a certificate from employer or manager.
Additional selection criteria for direct entry into the second year of the programme: Master year 1 level
(240 ECTS credits / 4 years) or equivalent in Health or Life sciences or
For professionals (i.e. in relevant employment): Bachelors’ degree (180 ECTS credits/3 years) or equivalent, and three years relevant professional experience.
For all applicants:
A personal letter of motivation to participate in the Eu2P Master including wishes on a research project topic.
Evidence of appropriate English language skills The programme is subject to the University's Principles, Policies, Regulations and Procedures for the Admission of Students to Undergraduate and Taught Postgraduate Programmes and will take account of University policy and guidelines for assessing accredited prior certificated learning (APCL) and accredited prior experiential learning (APEL).
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
10
Section 2 Programme management Relevant QAA subject benchmarking statements None Date of validation/last periodic review June 11 Date of production/ last revision of PS May 2011 Relevant intakes Level 7 entering September 2011 FROM GRADUATING Administrative School School of Life and Medical Sciences
The programme is managed by; The Eu2P Education Board, the membership of which includes:
Permanent members: - One member from each of Academic Partners to be chosen among the domains directors,
Modules coordinators or Eu2P teaching teams members, - The representatives of Associated Members that are domain co-directors, - One representative of an Academic Partner dedicated to quality aspects, - One representative of an Associated Member dedicated to quality aspects, - One representative of an Academic Partner dedicated to communication aspects, - One representative of an Associated Member dedicated to communication aspects, - One representative of an Academic Partner dedicated to e-learning aspects, - One representative of an Associated Member dedicated to e-learning aspects.
Additional members:
Representatives of Eu2P trainees will be invited to the Education Board meetings when the agenda of the Education Board requires such attendance. Such representatives will be elected by their fellow trainees during the freshers’ week on the following basis:
Two representatives of the trainees enrolled in the first year of the Master- Two representatives of the trainees enrolled in the second year of the programme
The Eu2P Administrative Committee, the membership of which includes: one member of each Eu2P partner’s administrative staff to serve as the local administrative contact person for the Eu2P central office.
Domain Directors responsible for the academic coherence of each Domain of modules
Module Coordinators responsible for the day-to-day operation of modules.
Eu2P Central Office The responsibilities of the central office shall include but not be limited to responsibility for all operational activities relating to: - Course catalogue & calendar database - Trainee application & database - Trainer services - Trainee services - Fees (collection, redistribution) and grants (files and payment) - Research projects & mobility - Quality procedures - Communication activities - Qualification procedures - Organise any face-to-face assessments according to module calendar and team needs. These
assessments can either take place on-line (via Adobe connect videoconference) or physically in a central place (e.g., Eu2P university) or place near the student. Students will be expected to follow the examination rules set out by the Academic Partner to which the Module coordinator belongs.
Programme-specific assessment regulations
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
11
The programme is compliant with the University's academic regulations (UPR AS11, UPR AS12 or UPR AS13, UPR AS14) with the exception of those listed below, which have been specifically approved by the University:
“Eu2P Master Trainee Regulations: The Master Trainee’s code of rights and obligations”
“Eu2P Certificate Trainee regulations: The Certificate Trainee’s code of rights and obligations”
Other sources of information
Eu2P Standard Operating Procedures (SOPs)
Definitive Module Documents
Module Guides
Student Handbook
University of Hertfordshire Course website: http://www.herts.ac.uk/courses/
QAA Benchmark Statement website: http://www.qaa.ac.uk/academicinfrastructure/benchmark/default.asp
Frameworks for Higher Education Qualifications of UK Degree-Awarding Bodies (2014)
The Frameworks for Higher Education Qualifications of UK Degree-Awarding Bodies
SEEC Credit Level Descriptors for Further and Higher Education 2010: http://www.seec.org.uk/academic-credit/seec-credit-level-descriptors-2010
External Quality Review report website: http://www.qaa.ac.uk/reviews/reports/instReports.asp?ukprn=10007147
Professional or Statutory Regulatory Body information: <insert URL>
UNISTATS website: http://www.unistats.com/
University of Hertfordshire Academic Quality Office website: (StudyNet Staff Department Lists Academic Quality Office)
Structure & Assessment Regulations - Undergraduate & Taught Postgraduate Programmes, UPR AS14:
http://sitem.herts.ac.uk/secreg/upr/AS14.htm
Learning and Teaching Policy and Graduate Attributes, UPR TL03: http://sitem.herts.ac.uk/secreg/upr/TL03.htm
Admissions - Undergraduate & Taught Postgraduate Students, UPR SA03: http://sitem.herts.ac.uk/secreg/upr/SA03.htm
Academic Quality, UPR AS17: http://sitem.herts.ac.uk/secreg/upr/AS17.htm
Index of UPRs for students: http://sitem.herts.ac.uk/secreg/upr_azlist_info.htm
Information on Programme and Module External Examiners http://www.studynet1.herts.ac.uk/ptl/common/studentcentre.nsf/Teaching+Documents/184A221E5EECA6B780257A5C00250BA9?OpenDocument
Other information relevant to the programme
University policies relevant to the Programme The University undertakes to use all reasonable endeavours to deliver, assess and administer this programme in accordance with this Programme Specification. At the same time it is recognised that it is
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
12
in the nature of academic developments that changes, for example to the structure, curriculum, and assessment of a programme may be necessary in order to ensure that the programme remains up to date, in response to issues raised as a result of on-going monitoring and evaluation, and/or in order to conform to new regulatory requirements imposed by this institution, by professional or statutory bodies, or by national or governmental bodies. The programme operates within the guidelines and policies relating to equal opportunities and environmental issues which may be agreed from time to time by the Board of Governors and/or the Academic Board of the University. Where the programme is offered in collaboration with another institution these policies and guidelines will normally be those of the partner institution. The programme operates in accordance with the University's Regulations Governing Studies Involving the Use of Human Subjects (UPR RE01) agreed from time to time by the Academic Board of the University. However, where the programme is offered in collaboration with another institution (for example through a franchise arrangement for all or part of the programme) then specific approval must be obtained from the University for the operation of the programme within ethical guidelines prepared by the partner institution. The partner institution will be responsible for all insurance liability in connection with the observance of ethical guidelines.
Signed ………… ………… Date…22 October 2015…
Philomena Shaughnessy Associate Dean of School (Academic Quality Assurance)
If you would like this information in an alternative format please contact: Student Administrator
Eu2p MSc Pharmacovigilance and Pharmacoepidemiology
Table 2: Development of Programme Learning Outcomes in the Constituent Modules This map identifies where the programme learning outcomes are assessed in the constituent modules. It provides (i) an aid to academic staff in understanding how individual modules contribute to the programme aims (ii) a checklist for quality control purposes and (iii) a means to help students monitor their own learning, personal and professional development as the programme progresses.
Programme Learning Outcomes (as identified in section 1 and the following page)
Module Title Module Code A1 A2 A3 A4 A6 B1 B2 B3 B4 C1 C2 C3 C4 C5 D1 D2 D3 D4 D5
Year 1
Basics in epidemiology applied to PV and PE D1M1
Basics in statistics applied to PV and PE D1M2
Tools to do research applied to PV and PE D1M3
Basics in clinical pharmacology D2M1
Principles of pharmacovigilance* D3M1
Basics in pharmacoepidemiology D6M1
Basics in communication applied to PV and PE D7M1
Tutored project
Research project 1
Clinical and pharmacological principles of PV and
PE
D2M2
PV regulations D3M2
Principles of recognizing adverse events and
safety signals
D4M1
Introduction to benefit risk assessment and
pharmacoeconomics in decision making
D5M1
Drug utilization studies: introduction and
quantitative methods
D6M2
Needs and objectives in communication risk and
benefit-risk related to medicines
D7M2
Le
ve
l 7
Practical SkillsKnowledge &
Understanding
A5
Year 2
Transferable
Skills
Intellectual
Skills
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
14
Programme Learning Outcomes (as identified in section 1 and the following page)
Module Title Module Code A1 A2 A3 A4 A5 A6 B1 B2 B3 B4 C1 C2 C3 C4 C5 D1 D2 D3 D4 D5
Optional
Methods in clinical research, PE and the
assessment of efficacy of medicines
D2M3
Critical appraisal of clinical trials: Evidence-based
medicine and its uncertainties
D2M4
PV regulatory processes D3M3
Substantiation of risks 1 D4M2a
Substantiation of risks 2 D4M2b
Identifying susceptibility to adverse drug reactions D4M3
Principles of pharmacoeconomics and valuation of
health states
D5M2
Methods for quantitative benefit-risk assessment
of medicines
D5M3
Application of quantitative benefit-risk assessment
in decision making on medicines
D5M4
Drug utilization studies: qualitative methods D6M3
The public health impact of adverse drug reactions D6M4
Transferable
Skills
Le
ve
l 7
Knowledge &
Understanding
Intellectu
al Skills Practical Skills
Key: Learning Outcome which is assessed as part of the module
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
15
Table 3: Grading equivalents for Eu2P Academic Partners
Eu2P grades translation
Université Bordeaux Segalen
University of Hertfordshire
Universiteit Utrecht
Erasmus Universitair Medisch Centrum Rotterdam
Universitat Autònoma de Barcelona
Università di Verona
A+ Excellent 16,0 - 20 80 - 100 8,5 - 10 8,5 - 10 8,0 - 10 29 - 30 lode
A Very Good
14,0 – 15,9 70 - 79 7,5 - 8,4 7,5 - 8,4 7,0- 7,9 27 - 28
B Good 12,0 – 13,9 60 - 69 7,0 - 7,4 7,0 - 7,4 5,6 - 6,9 23 - 26
C Pass 10,0 – 11,9 50 - 59 5,5 - 6,9 5,5 - 6,9 5,0 - 5,5 18 - 22
F Fail 0 - 9,9 0 - 49 0 - 5,4 0 - 5,4 0 - 4, 9 0 - 17
V1.9 /Master’s Programme Specification / July 2015 / AS © University of Hertfordshire 2014
16
Key to Programme Learning Outcomes
Knowledge and Understanding eg Practical Skills
A1.-the main epidemiological and statistical principles, concepts and tools that are used in pharmacoepidemiology and pharmacovigilance practices and research
C1. apply the main health indices used to describe mortality and morbidity of
the population
A2. the worldwide regulations and guidelines concerning pharmacovigilance C2. apply the methodology used in epidemiological studies and randomized
clinical trials to assess the efficacy and effectiveness of medicine
A3. the clinical, pharmacological and epidemiological principles underlying the prescribing of medicines and their effectiveness evaluation.
C3. qualitatively and quantitatively analyse the utilization of medicines
A4. the principles of PV from the development of the science to its place in pre and post-authorisation environment and the roles of various stake holders within PV
C4. design studies and write protocols to quantify and analyse safety signals
or risks
A5. the evaluation of the effects of medicines from epidemiological and public health points of view
C5. apply benefit-risk assessment methods in daily practice
A6. the principles of medicines risk communication, its tools and its place in mitigating risks linked to the use of medicines
Intellectual Skills eg Transferable Skills
B1. discuss and analyse the need to solve therapeutic uncertainties through clinical research
D1. communicate written and oral scientific results
B2. analyse benefit-risk assessment methods (including pharmacoeconomics), the process of decision making and communication on medicines by different stakeholders
D2 present and support an extended argument
B3. To identify and quantify risks of medicine, interpret publications and results D3. demonstrate the ability to carry out a defined task, solve it in a set period
of time and adequately report the results of this work in a written report and in an oral presentation
D4. demonstrate skills in searching medical and scientific literature
D5. manage information